Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties
Claudia Finamore,
Giuliana Baronissi,
Silvia Marchianò,
Francesco Saverio Di Leva,
Adriana Carino,
Maria Chiara Monti,
Vittorio Limongelli,
Angela Zampella,
Stefano Fiorucci,
Valentina Sepe
Affiliations
Claudia Finamore
Department of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy
Giuliana Baronissi
Department of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy
Silvia Marchianò
Department of Surgery and Biomedical Sciences, Nuova Facoltà di Medicina, Piazza Lucio Severi, 1 - 06132 Perugia, Italy
Francesco Saverio Di Leva
Department of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy
Adriana Carino
Department of Surgery and Biomedical Sciences, Nuova Facoltà di Medicina, Piazza Lucio Severi, 1 - 06132 Perugia, Italy
Maria Chiara Monti
Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy
Vittorio Limongelli
Department of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy
Angela Zampella
Department of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy
Stefano Fiorucci
Department of Surgery and Biomedical Sciences, Nuova Facoltà di Medicina, Piazza Lucio Severi, 1 - 06132 Perugia, Italy
Valentina Sepe
Department of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy
As a cellular bile acid sensor, farnesoid X receptor (FXR) and the membrane G-coupled receptor (GPBAR1) participate in maintaining bile acid, lipid, and glucose homeostasis. To date, several selective and dual agonists have been developed as promising pharmacological approach to metabolic disorders, with most of them possessing an acidic conjugable function that might compromise their pharmacokinetic distribution. Here, guided by docking calculations, nonacidic 6-ethyl cholane derivatives have been prepared. In vitro pharmacological characterization resulted in the identification of bile acid receptor modulators with improved pharmacokinetic properties.